In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...

Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in young children.

Federal documents show he disagreed with conclusions the benefits outweighed the risk of side effects, which are rare.

The approval comes amid regulatory upheaval under HHS head Robert F. Kennedy Jr., who has pushed for changes around mRNA ...

Both vaccines were approved by the FDA in May after months of analysis by rank-and-file FDA reviewers. But internal correspondence show Prasad disagreed with staffers who planned to approve the ...

H. Gilbert Welch and Vinay Prasad write that since the pandemic forced the medical care system to cancel elective surgeries and have fewer outpatient visits, Covid-19 provides a once in a lifetime ...

FDA Commissioner Marty Makary selected Dr. Vinay Prasad, a prominent critic of COVID-19 boosters, to lead the Center for Biologics Evaluation and Research.

Days after the Journal piece, Prasad — who at the time claimed to be a political “liberal” in the vein of Elizabeth Warren and Bernie Sanders — argued in a YouTube video, as he wrote in ...

Prasad's following grew during the COVID-19 pandemic, as he criticized measures like vaccine mandates and called for Moderna's vaccine to be banned in men under 40.. During the pandemic, he was ...

Vinay Prasad, MD, MPH, a frequent critic of the FDA and COVID-19 lockdowns and vaccination policies, will be the next director of FDA's Center for Biologics Evaluation and Research (CBER), the ...

Annual COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift unveiled Tuesday by the Trump administration.